Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Surgery Partners Inc. shares valued at $4,803 were sold by Brocklehurst Laura L. on Aug 30. At $29.65 per share, Brocklehurst Laura L. sold 162 shares. The insider’s holdings dropped to 45,762 shares worth approximately $1.14 million following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, Doherty David T sold 171 shares, netting a total of over 5,070 in proceeds. Following the sale of shares at $29.65 each, the insider now holds 58,579 shares.
Before that, Brocklehurst Laura L. had sold 196 shares from its account. In a trade valued at $5,831, the Chief Human Resources Officer traded Surgery Partners Inc. shares for $29.75 each. Upon closing the transaction, the insider’s holdings decreased to 196 shares, worth approximately $1.14 million.
As published in a research note from BofA Securities on June 15, 2022, Surgery Partners Inc. [SGRY] has been rated down from a Buy to a Neutral and the price target has been revised to $36 from $55. This represents a 30.81% premium over Thursday’s closing price. As of November 30, 2021, Barclays has initiated its “an Overweight” rating for SGRY. Earlier on November 29, 2021, Stifel upgraded its rating. Their new recommendation was “a Buy” for SGRY stock which previously was a “a Hold”.
Analyzing SGRY’s Price Performance
On Thursday, Surgery Partners Inc. [NASDAQ: SGRY] plunged -7.02% to $24.91. The stock’s lowest price that day was $24.43, but it reached a high of $26.92 in the same session. During the last five days, there has been a drop of approximately -14.95%. Over the course of the year, Surgery Partners Inc. shares have dropped approximately -53.36%. Shares of the company reached a 52-week high of $63.87 on 04/21/22 and a 52-week low of $24.05 on 09/01/22. A 50-day SMA is recorded $33.09, while a 200-day SMA reached $42.92. Nevertheless, trading volume fell to 1.02 million shares from 0.87 million shares the previous day.
Support And Resistance Levels for Surgery Partners Inc. (SGRY)
According to the 24-hour chart, there is a support level at 23.92, which, if violated, would cause prices to drop to 22.93. In the upper region, resistance lies at 26.41. The next price resistance is at 27.91. RSI (Relative Strength Index) is 30.09 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.09, which suggests the price will decrease in the coming days. Percent R is at 93.58%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Surgery Partners Inc. subject to short interest?
Stocks of Surgery Partners Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.31 million shares to 4.23 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 3.92 million shares. A jump of 7.33% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.56 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.56.
Which companies own the most shares of Surgery Partners Inc. (SGRY)?
According to Fidelity Management & Research Co filings, the company currently owns 12,222,567 shares, which is about 13.59% of the total SGRY shares outstanding. The investor’s shares have appreciated by 1,452,027 from its previous 13-F filing of 10770540.0 shares. With the completion of the buy transaction, ClearBridge Investments LLC’s stake is now worth $119,530,773. The Vanguard Group, Inc. acquire a 1.71% interest valued at $100.66 million while BlackRock Fund Advisors purchased a 256,329 stake. A total of -472,157 shares of Surgery Partners Inc. were bought by T. Rowe Price Associates, Inc. during the quarter, and -224,170 were sold by Durable Capital Partners LP. In its current portfolio, Invesco Advisers, Inc. holds 1,503,297 shares valued at $41.39 million.
In terms of Surgery Partners Inc. share price expectations, FactSet research, analysts set an average price target of $54.56 in the next 12 months, up nearly 112.77% from the previous closing price of $26.79. Analysts anticipate Surgery Partners Inc. stock to reach $72.00 by 2022, with the lowest price target being $34.00. On November 01, 2021, JP Morgan assigned a price target of “a Neutral” to the stock and initiated coverage with a $50.